| Officer | Age | 2025 pay | Source |
|---|---|---|---|
|
Douglas E. Onsi
Also a director
CEO,CFO,Pres.,GC,Treas.&Sec.
Title from the Form 4 dated Jul 1, 2026
|
57 | $4,744,255 | |
|
William Patrick McEvoy III
Chief Investment Officer
Title from the Form 4 dated Oct 12, 2026
|
Not stated | Not reported | |
|
Kevin Zhang
Head of Mining
Title from the Form 4 dated Aug 21, 2026
|
Not stated | Not reported | |
|
Will McEvoy
Also a director
Executive officer
|
30 | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 29, 2026 · updated by the 8-K of Sep 22, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Khing Oei
Board chair
|
50 | Not stated | Not stated | None stated | None stated | $6,578,111 | |
|
Douglas E. Onsi
CEO, Executive officer
|
57 |
2020
6 years
|
Not stated | None stated | None stated | Paid as CEO | |
|
Thomas Dietz
Lead independent director
|
62 |
2016
10 years
|
Not stated | None stated | None stated | $267,123 | |
|
Will McEvoy
Executive officer
|
30 |
2026
this year
|
Not stated | None stated | None stated | Not stated | |
|
Nissim Mashiach
|
65 |
2017
9 years
|
Independent |
Audit Committee
Nominating and Corporate Governance Committee
|
Mediwound Ltd. | $198,660 | |
|
Christian Richard
|
56 |
2023
3 years
|
Independent |
Audit Committee
Nominating and Corporate Governance Committee
|
None stated | $198,660 | |
|
William Li
|
63 |
2017
9 years
|
Not stated | None stated | None stated | $203,660 | |
|
Patricia Martin
|
Not stated | Not stated | Independent | None stated | None stated | $203,660 | |
|
Amanda Fabiano
Joined Sep 22, 2026
|
- | - | - | - | - | - | |
|
Joseph Loscalzo
Leaving at the meeting
|
74 |
2016
10 years
|
Not stated |
Nominating and Corporate Governance Committee
|
Ionis Pharmaceuticals, Inc. | $194,160 | |
|
Christopher Mirabelli
Leaving at the meeting
Board chair
|
71 |
2011
15 years
|
Not stated | None stated | None stated | Not stated | |
|
James Cavanaugh
Leaving at the meeting
|
89 |
2016
10 years
|
Not stated |
Nominating and Corporate Governance Committee · Chair
Audit Committee
|
None stated | $208,660 | |
|
Richard Schilsky
Leaving at the meeting
|
75 |
2022
4 years
|
Not stated |
Nominating and Corporate Governance Committee
|
None stated | $194,160 |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...